Cushing’s syndrome and ACTH-dependent hypercortisolism
Sparrow Pharmaceuticals Inc. focuses on clinical research in Cushing’s syndrome, including ACTH-dependent forms such as Cushing’s disease, ectopic ACTH secretion, and ectopic corticotrophin-releasing hormone–driven disease. The sponsor’s work in this area centers on disorders of excess cortisol production and related endocrine dysregulation.
- Endocrinology
- Hypercortisolism
- Adrenal and pituitary disorders
Its trial portfolio also includes patients with hypercortisolism linked to benign adrenal tumours and autonomous cortisol secretion.
Polymyalgia rheumatica
The sponsor is also active in polymyalgia rheumatica, with studies examining treatment use alongside prednisolone in adults living with this inflammatory rheumatic condition. This reflects interest in conditions requiring careful management of glucocorticoid therapy and symptom control.
- Rheumatology
- Inflammatory disorders
- Glucocorticoid-treated disease
Research activity in this area includes both PMR and related clinical presentations described under the same disease spectrum.
Adrenal steroid regulation
Across its studies, Sparrow Pharmaceuticals Inc. shows a clear therapeutic interest in steroidogenesis and the regulation of cortisol metabolism. The sponsor’s research spans disorders where abnormal adrenal hormone production contributes to systemic complications and long-term disease burden.
- Adrenal endocrinology
- Cortisol excess
- Steroid metabolism
These programs connect endocrine and inflammatory indications through a shared focus on hormone balance and glucocorticoid-related clinical management.
